The study brochure about the new Miebach pharma survey 2016 with 256 participants is now available. The results show: The pharmaceutical industry is giving its supply chain and logistics a much greater importance than in the past. The top subjects in the pharmaceutical logistics are end-to-end supply chain visibility and optimizing the distribution networks. The increasing volume of refrigerated and frozen products and serialization of product codes are further challenges supply chain managers are facing.
“Our European study clearly shows that most pharmaceutical companies see the European market as a whole region, while national borders are becoming less important, except for specific legislation or distribution channels” – says Martin Eckert, Global Pharma Expert & Director, Miebach Consulting. Optimization of the distribution network has grown very much in importance (from 76 % to 86 %). The initiatives are aiming to transform many national networks into one more efficient and transparent European network, alongside with other many issues.
Topics like improving supplier management (86 %), end-to-end supply chain visibility (93 %), improving forecasting accuracy (84 %) and track & trace (82 %) are some of the most significant issues for the management, very much in line with the previous Miebach pharma study from 2012. Optimization through automation (64 %), outsourcing (62 %) and constructing new warehouses compliant with GxP guidelines (54 %) are also important topics.
The full study report including derived recommendations for action (in English language) can be obtained here.